I am bullish on AbCellera Biologics Inc. (NASDAQ: ABCL ), driven by long-term outlook gains expected from the completion of the clinical manufacturing facility by the end of 2025. The companyFirst Principles Partners is an equity research analyst specializing in technology, innovation, and sustainability investment. My unique approach, "First Principles," involves breaking down complex problems to their most basic elements in terms of financial and technology, enabling me to uncover overlooked investment op ...